Clinical Factors and Rate of Cough During Angiotensin‐Converting Enzyme Inhibitor Treatment

Clinical Pharmacology & TherapeuticsVolume 105, Issue 3 p. 566-566 Letter to the Editor Clinical Factors and Rate of Cough During Angiotensin-Converting Enzyme Inhibitor Treatment Huan Ren, Huan Ren Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China Institute of Clinical Pharmacology, Central South University, Changsha, China Hunan Key Laboratory of Pharmacogenetics, Changsha, ChinaSearch for more papers by this authorJian-Quan Luo, Jian-Quan Luo Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, ChinaSearch for more papers by this authorYan Shu, Yan Shu Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD, USASearch for more papers by this authorHong-Hao Zhou, Hong-Hao Zhou Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China Institute of Clinical Pharmacology, Central South University, Changsha, China Hunan Key Laboratory of Pharmacogenetics, Changsha, ChinaSearch for more papers by this authorWei Zhang, Wei Zhang yjsd2003@163.com Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China Institute of Clinical Pharmacology, Central South University, Changsha, China Hunan Key Laboratory of Pharmacogenetics, Changsha, ChinaSearch for more papers by this author Huan Ren, Huan Ren Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China Institute of Clinical Pharmacology, Central South University, Changsha, China Hunan Key Laboratory of Pharmacogenetics, Changsha, ChinaSearch for more papers by this authorJian-Quan Luo, Jian-Quan Luo Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, ChinaSearch for more papers by this authorYan Shu, Yan Shu Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD, USASearch for more papers by this authorHong-Hao Zhou, Hong-Hao Zhou Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China Institute of Clinical Pharmacology, Central South University, Changsha, China Hunan Key Laboratory of Pharmacogenetics, Changsha, ChinaSearch for more papers by this authorWei Zhang, Wei Zhang yjsd2003@163.com Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China Institute of Clinical Pharmacology, Central South University, Changsha, China Hunan Key Laboratory of Pharmacogenetics, Changsha, ChinaSearch for more papers by this author First published: 18 September 2018 https://doi.org/10.1002/cpt.1218 Correspondence: Wei Zhang (yjsd2003@163.com) Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume105, Issue3From Molecule to PatientMarch 2019Pages 566-566 RelatedInformation